Skip to main content

Table 1 Patients’ characteristics

From: The effect of tumor volume and its change on survival in stage III non-small cell lung cancer treated with definitive concurrent chemoradiotherapy

Characteristics n (%)
Age (y) Median (range) 63 (range, 27–81)
Sex Male 137 (87%)
  Female 20 (13%)
Performance ECOG 0 39 (25%)
  ECOG 1 111 (71%)
  ECOG 2 7 (4%)
Histology Squamous cell carcinoma 86 (55%)
  Adenocarcinoma 52 (33%)
  Large cell carcinoma 2 (1%)
  NSCLC, NOS 17 (11%)
T stage 1 18 (11%)
  2 61 (39%)
  3 34 (22%)
  4 44 (28%)
N stage 0 3 (2%)
  1 3 (2%)
  2 75 (48%)
  3 76 (48%)
Stage IIIA 49 (31%)
  IIIB 108 (69%)
  1. Abbreviations: ECOG Eastern Cooperative Oncology Group, NSCLC Non-small-cell lung cancer, NOS Not otherwise specified.